Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Dutasteride and Imidafenacin in BPH/OAB patients not respond to eight weeks'continuous treatment of Tamsulosin.

Next Previous
X
Search
Trial Profile

Effect of Dutasteride and Imidafenacin in BPH/OAB patients not respond to eight weeks'continuous treatment of Tamsulosin.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 30 Apr 2019

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imidafenacin (Primary) ; Dutasteride
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms DIrecT
  • Sponsors Kyorin Pharmaceutical

    • Most Recent Events

    • 16 Sep 2016 Results of subgroup analysis (n=163) presented at the 46th Annual Meeting of the International Continence Society.
    • 07 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 15 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan .

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top